Elkind-Hirsch, Karen E <br/><br/>
Short-term therapy with combination dipeptidyl peptidase-4 inhibitor saxagliptin/metformin extended release (XR) is superior to saxagliptin or metformin XR monotherapy in prediabetic women with polycystic ovary syndrome: a single-blind, randomized, pilot study.  [electronic resource] 

 -  Fertility and sterility  01 2017 
 - 253-260.e1 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1556-5653 
<br/><br/><label>Standard No.: </label>10.1016/j.fertnstert.2016.09.023  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adamantane--administration & dosage<br/>Adiposity--drug effects<br/>Adolescent<br/>Adult<br/>Androgens--blood<br/>Biomarkers--blood<br/>Blood Glucose--drug effects<br/>Delayed-Action Preparations<br/>Dipeptides--administration & dosage<br/>Dipeptidyl-Peptidase IV Inhibitors--administration & dosage<br/>Drug Administration Schedule<br/>Drug Combinations<br/>Female<br/>Glucose Tolerance Test<br/>Humans<br/>Hypoglycemic Agents--administration & dosage<br/>Insulin--blood<br/>Menstrual Cycle--drug effects<br/>Metformin--administration & dosage<br/>Pilot Projects<br/>Polycystic Ovary Syndrome--blood<br/>Prediabetic State--blood<br/>Single-Blind Method<br/>Time Factors<br/>Treatment Outcome<br/>Young Adult